S837 treatment with imetelstat provides durable transfusion independence (ti) in heavily transfused non-del(5q) lower risk mds (lr-mds) relapsed/refractory (r/r) to erythropoiesis stimulating agents (esas)

P. Fenaux,D.P. Steensma, K. Van Eygen, A. Raza, V. Santini, U. Germing, P. Font, M. Díez-Campelo, S. Thepot, E. Vellenga, M.M. Patnaik, J.H. Jang, L. Sherman, L. Sun, H. Varsos, A. Rizo, Y. Wan, F. Huang, J. Bussolari, E. Rose,U. Platzbecker

HemaSphere（2019）

引用 6|浏览0

暂无评分

关键词

erythropoiesis stimulating agents,durable transfusion independence,imetelstat,non-del,lr-mds

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要